GRF-P

Grifols SA

Stock Bolsas y Mercados Españoles – Stock Market Prices, News & Analysis

Grifols SA is a Spanish multinational company specialized in the production of plasma-derived biopharmaceutical products.

€ 6.96
1.14 %

Grifols SA

6.96
1.14 %
GRF-P

Grifols SA is a Spanish multinational company specialized in the production of plasma-derived biopharmaceutical products.

Price history of Grifols SA
Price history of Grifols SA

Performance & Momentum

6 Months 10.56 %
1 Year 22.17 %
3 Years 9.32 %
5 Years 49.19 %

Strategic Analysis

Grifols SA • 2026

Grifols SA operates in the niche of biopharmaceutical products derived from plasma, an essential sector for specialized medical treatments. It stands out due to its significant presence in Spain and the development of cutting-edge medical , allowing it to position itself as a key player in the healthcare and biotechnology sector.

Strengths
  • Leadership position in the plasma-derived products niche
  • Continuous innovation in medical
  • Strong presence and recognition in the Spanish market
Weaknesses
  • Historically volatile financial performance
  • Significant loss of value over the medium and long term
Momentum

Despite a relatively low momentum, Grifols SA shows signs of recovery over the past year. This trend could indicate a potential rebound or stabilization, driven by innovation efforts and a strategic adaptation by the group in response to sector challenges.

Similar stocks to Grifols SA

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone